年龄与女性乳腺癌结果有U形关系:一项队列研究
Yujie Xie1, Yongqing Deng2, Suosu Wei3
1Department of Breast and Thyroid Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
Frontiers in oncology
|October 20, 2023
概括
在年轻或年长时被诊断为乳腺癌的患者面临更糟糕的结果. 这项研究发现,诊断时的年龄与整体存活率,乳腺癌特异性存活率和无疾病存活率之间存在U形关联.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 生物统计学 生物统计学
背景情况:
- 年龄是影响乳腺癌易感性和预后的关键因素.
- 关于诊断年龄和乳腺癌结果之间的非线性关系的现有研究是矛盾的.
- 关于诊断时的年龄如何影响乳腺癌患者生存率的数据有限.
研究的目的:
- 调查诊断时的年龄与乳腺癌患者预后之间的关联.
- 分析年龄对整体存活率 (OS),乳腺癌特定存活率 (BCSS) 和无病存活率 (DFS) 的影响.
主要方法:
- 对1054名乳腺癌患者进行了回顾性队列研究.
- 使用了考克斯的比例危险比率模型和限制立方线 (RCS).
- 评估危险比率 (HRs) 和生存结果的95%置信区间 (CI).
主要成果:
- 在诊断时的年龄和OS,BCSS和DFS之间观察到一个U形的关联.
- 在年轻和年长的年龄极端中,人们注意到不良结果的风险更高.
- 年龄转折点在OS和BCSS的44岁,DFS的41岁时被确定.
结论:
- 这项研究证实了诊断时的年龄和乳腺癌结果之间存在显著的U形关系.
- 在诊断时,年轻和年长的患者均表现出较差的生存率.
- 这些发现强调了年龄在乳腺癌预后中的复杂作用.
相关概念视频
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Actuarial Approach
80
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
80
Life Histories
18.0K
Overview
18.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Comparing the Survival Analysis of Two or More Groups
201
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
201


